Cannabinoid receptor antagonist SR141716A decreases operant ethanol self administration in rats exposed to ethanol-vapor chambers

Acta Pharmacologica Sinica

Volumn 20, Issue 12, 1999, Pages 1109-1114

  Rodríguez De Fonseca, Fernando ^a   Roberts, Amanda J ^b   Bilbao, Ainhoa ^a   Koob, George F ^b   Navarro, Miguel ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Cannabinoid receptors; Ethanol; Self administration; SR141716A

Indexed keywords

ALCOHOL; CANNABINOID RECEPTOR; CANNABINOID RECEPTOR ANTAGONIST; RIMONABANT;

ALCOHOL CONSUMPTION; ALCOHOLISM; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; FOOD INTAKE; INSTRUMENTAL CONDITIONING; MALE; NONHUMAN; RAT;

ALCOHOLISM; ANIMALS; CANNABINOIDS; CONDITIONING, OPERANT; ETHANOL; MALE; PIPERIDINES; PYRAZOLES; RATS; RATS, WISTAR; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; SELF ADMINISTRATION; SUBSTANCE-RELATED DISORDERS;

EID: 0032794966     PISSN: 02539756     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Gardner EL, Vorel SR. Cannabinoid transmission and reward-related events. Neurobiol Disease 1998; 5: 502-33.
2. Tanda G, Pontieri FE, Di Chiara G. Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common μ-opioid receptor mechanism. Science 1997; 276: 2048-50.
3. 1 receptors. Eur J Pharmacol 1998; 341: 39-44.
4. Banerjee SP, Snyder SH, Mechoulam R. Cannabinoids: influence on neurotransmitter uptake in rat brain synaptosomes. J Pharmacol Exp Ther 1975; 194: 74-81.
5. Maneuf YP, Nash JE, Crossman AR, Brotchie JM. Activation of the cannabinoid receptor by delta-9-tetrahydrocannabinol reduces gamma-aminobutyric acid uptake in the globus pallidus. Eur J Pharmacol 1996; 306: 161-4.
6. Mailleux P, Vanderhaeghen JJ. Delta-9-tetrahydro-cannabinol regulates substance P and enkephalin mRNAs levels in caudate putamen. Eur J Pharmacol 1994; 267: R1-R3.
7. 9-Tetrahydrochannabinol increases proopiomelanocortin gene expression in the arcuate nucleus of the rat hypothalamus. Eur J Pharmacol 1997; 323: 193-5.
8. 1 cannabinoid receptor antagonist-induced opiate withdrawal in morphine-dependent rats. Neuroreport 1998; 9: 3397-402.
9. Weidenfeld J, Feldman S, Mechoulam R. Effect of the brain constituent anandamide, a cannabinoid receptor agonist, on the hypothalamo-pituitary-adrenal axis in the rat. Neuroendocrinology 1994; 59:110-12.
10. Rodríguez de Fonseca F, Carrera MR, Navarro M, Koob GF, Weiss F. Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal. Science 1997; 276: 2050-54.
11. Comings DE, Muhleman D, Gade R, Johnson P, Verde R, Saucier G, et al. Cannabinoid receptor gene (CNR1) association with iv drug use. Mol Psychiatry 1997; 2: 161-8.
12. Johnson JP, Muhleman D, MacMurray J, Gade R, Verde R, Ask M, et al. Association between the cannabinoid receptor gene (CNR1) and the P300 event-related potential. Mol Psychiatry 1997; 2: 169-71.
13. Begleiter H, Porjesz B, Bihari B, Kissin B. Event-related brain potentials in boys at risk for alcoholism. Science 1984; 225: 1493-6.
14. Diana M, Melis M, Muntoni AL, Gessa GL. Mesolimbic dopaminergic decline after cannabinoid withdrawal. Proc Natl Acad Sci USA 1998; 95: 10269-73.
15. Gonzales RA, Weiss F. Suppression of ethanol-reinforced behavior by naltrexone is associated with attenuation of the ethanol-induced increase in dialysate dopamine levels in the nucleus accumbens. J Neurosci 1998; 18: 10663-71.
16. Schulteis G, Markou A, Cole M, Koob GF. Decreased brain reward produced by ethanol withdrawal. Proc Natl Acad Sci USA 1995; 92: 5880-4.
17. Pich EM, Lorang M, Yeganeh M, Rodriguez de Fonseca F, Raber J, Koob GF, et al. Increase of extracellular corticotropin-releasing factor-like inmunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis. J Neurosci 1995; 15: 5439-47.
18. Rinaldi-Carmona M, Barth F, Heaulme M, Shire D, Calandra B, Congy C, et al. SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett 1994; 350: 240-4.
19. 1) receptors. Psycnopnarmacology 1997; 132: 104-6.
20. Gallate JE, McGregor IS. The motivation for beer in rats: effects of ritanserin, naloxone and SR141716A. Psychopharmacology 1999; 142; 302-8.
21. Colombo G, Agabio R, Fa M, Guano L, Lobina C, Loche A, et al. Reduction of voluntary ethanol intake in ethanol-preferring sP rats by die cannabinoid antagonist SR141716A. Alcohol Alcohol 1998; 33: 126-30.
22. 1 receptor agonist. Eur J Pharmacol 1999; 370: 233-40.
23. McMilian DE, Snodgrass SH. Effects of acute and chronic administration of delta-9-tetrahydrocannabinol or cocaine on ethanol intake in a rat model. Drug Alcohol Depend 1991; 27: 263-74.
24. Zemig G, Fabish K, Fabish H. Pharmacotherapy of alcohol dependence. Trends Pharmacol Sci 1997; 18: 229-31.
25. Volpicelli JR, Alterman AI, Hayashida M, O' Brien CP. Naltrexone in the treatment of alcohol dependence. Arch Gen Psychiatry 1992; 49: 876-80.
26. Roberts AJ, Cole M, Koob GF. Intra-amygdala muscimol decreases operant ethanol self-administration in dependent rats. Alcohol Clin Exp Res 1996; 20: 1289-98.
27. Samson HH. Initiation of ethanol reinforcement using a sucrose-substitution procedure in food- and water-sated rats. Alcohol Clin Exp Res 1986; 10: 436-42.
28. Basavarajappa BS, Hungund BL. Chronic ethanol increases the cannabinoid receptor agonist anandamide and its precursor W-arachidonoylphosphatidylethanolamine in SK-N-SH cells. J Neurochem 1999; 72: 522-8.
29. Basavarajappa BS, Cooper TB, Hungund BL. Chronic ethanol administration down-regulates cannabinoid receptors in mouse brain synaptic plasma membrane. Brain Res 1998; 793: 212-8.
30. 35 S-GTP-gamma S binding in synaptic plasma membrane from chronic ethanol-exposed mouse. Brain Res 1999; 815: 89-97.
31. 1 receptors in the rat central nervous system. Neuroscience 1998; 83: 393-411.
32. Hyythiä P, Koob GF. GABA-A receptor antagonism in the extended amygdala decreases ethanol self-administration in rats. Eur J Pharmacol 1995; 283: 151-9.
33. Giuffrida A, Parsons LH, Kerr TM, Rodriguez de Fonseca F, Navarro M, Piomelli D. Dopamine activation of endogenous cannabinoid signaling in dorsal striatum. Nature Neurosci 1999; 2: 358-63.
34. Rodriguez de Fonseca F, Navarro M. Role of the limbic system in dependence on drugs. Ann Med 1998; 30: 397-405.
35. Williams KL, Winger G, Pakarinen ED, Woods JH. Naltrexone reduces ethanol- and sucrose-reinforced responding in rhesus monkeys. Psychopharmacology 1998; 139: 53-61.